Home/Filings/4/0001123292-16-002364
4//SEC Filing

Recro Pharma, Inc. 4

Accession 0001123292-16-002364

CIK 0001588972operating

Filed

May 30, 8:00 PM ET

Accepted

May 31, 3:32 PM ET

Size

5.8 KB

Accession

0001123292-16-002364

Insider Transaction Report

Form 4
Period: 2016-05-26
McCallum Stewart
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2016-05-26$8.15/sh+1,000$8,1501,000 total
  • Purchase

    Common Stock

    2016-05-31$8.50/sh+250$2,1251,250 total

Issuer

Recro Pharma, Inc.

CIK 0001588972

Entity typeoperating
IncorporatedPA

Related Parties

1
  • filerCIK 0001588972

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 3:32 PM ET
Size
5.8 KB